Agenus | AGEN - Trade Creditors

Stock Price
3.01
Daily Change
-0.19 -5.94%
Monthly
2.38%
Yearly
28.09%
Q1 Forecast
3.23

Agenus reported $85.29M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 85.29M 10.89M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celldex Therapeutics USD 1.18M 3.09M Dec/2025
CSL USD 3.17B 290M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
Incyte USD 1.63B 1.46B Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 11.99B 2.37B Dec/2025
Jiangsu Hengrui CNY 2.22B 25.33M Sep/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Merck EUR 1.93B 32M Sep/2025
Merck USD 4.15B 102M Sep/2025
Northwest Biotherapeutics 27.22M 5.8M Mar/2025
Novartis USD 4.56B 49M Sep/2025
Novavax USD 15.23M 35.37M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Veracyte USD 4.59M 916K Dec/2025